Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.
Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.
Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on INSP stock, giving a Buy rating yesterday. Anthony ...
Piper Sandler raised the firm’s price target on Inspire Medical (INSP) to $260 from $255 and keeps an Overweight rating on the shares.
Q3 2024 Earnings Call Transcript November 4, 2024 Operator: Good afternoon. My name is Dilem, and I’ll be your conference ...
Inspire Medical Systems Sees Strong Q3 Growth in 2024 Inspire Medical raises FY24 EPS view to $1.20-$1.40 from 60c-80c Inspire Medical reports Q3 EPS 60c, consensus 8c ...
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization ...
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 55% bearish. Among these notable ...
GOLDEN VALLEY, Minn. (AP) — GOLDEN VALLEY, Minn. (AP) — Inspire Medical Systems Inc. (INSP) on Monday reported third-quarter net income of $18.5 million. The Golden Valley, Minnesota-based ...
My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems Third Quarter 2024 Conference Call. All lines have been ...